O. Kanat Et Al. , "Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status," WORLD JOURNAL OF CLINICAL CASES , vol.6, no.11, pp.418-425, 2018
Kanat, O. Et Al. 2018. Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status. WORLD JOURNAL OF CLINICAL CASES , vol.6, no.11 , 418-425.
Kanat, O., Ertas, H., & Caner, B., (2018). Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status. WORLD JOURNAL OF CLINICAL CASES , vol.6, no.11, 418-425.
Kanat, Ozkan, Hulya Ertas, And BURCU CANER. "Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status," WORLD JOURNAL OF CLINICAL CASES , vol.6, no.11, 418-425, 2018
Kanat, Ozkan Et Al. "Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status." WORLD JOURNAL OF CLINICAL CASES , vol.6, no.11, pp.418-425, 2018
Kanat, O. Ertas, H. And Caner, B. (2018) . "Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status." WORLD JOURNAL OF CLINICAL CASES , vol.6, no.11, pp.418-425.
@article{article, author={Ozkan Kanat Et Al. }, title={Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status}, journal={WORLD JOURNAL OF CLINICAL CASES}, year=2018, pages={418-425} }